Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jenny Yaohua Xue, M.D., Ph.D.

Concepts (72)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Jenny Xue's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Jenny Xue has written about over time.
Mutagenesis, 1 publications between 2019 and 2019, average publication date June 2019. Fibroblast Growth Factor 1, 1 publications between 2019 and 2019, average publication date September 2019. MAP Kinase Kinase 1, 1 publications between 2019 and 2019, average publication date September 2019. Receptor, Fibroblast Growth Factor, Type 1, 1 publications between 2019 and 2019, average publication date September 2019. Adaptation, Biological, 1 publications between 2020 and 2020, average publication date January 2020. Protein Kinase Inhibitors, 1 publications between 2020 and 2020, average publication date May 2020. Antineoplastic Agents, 4 publications between 2019 and 2021, average publication date June 2020. Neoplasms, 5 publications between 2019 and 2023, average publication date March 2021. Xenograft Model Antitumor Assays, 5 publications between 2019 and 2024, average publication date June 2021. Proto-Oncogene Proteins p21(ras), 6 publications between 2020 and 2023, average publication date June 2021. Lung Neoplasms, 4 publications between 2019 and 2024, average publication date July 2021. Proto-Oncogene Proteins B-raf, 4 publications between 2019 and 2024, average publication date August 2021. Drug Resistance, Neoplasm, 4 publications between 2019 and 2024, average publication date September 2021. Guanosine Triphosphate, 1 publications between 2021 and 2021, average publication date October 2021. RGS Proteins, 1 publications between 2021 and 2021, average publication date October 2021. GTP Phosphohydrolases, 2 publications between 2021 and 2021, average publication date October 2021. Mutation, 5 publications between 2020 and 2024, average publication date February 2022. Histone Deacetylase Inhibitors, 1 publications between 2024 and 2024, average publication date July 2024.

To see the data from this visualization as text, click here.
Xue's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (72)
Explore
_
Co-Authors (4)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.